Hyderabad-based Bharat Biotech has submitted data from Phase 3 clinical trials of BBV154, its intranasal Covid vaccine candidate, to the drug regulator.
Tata Consultancy Services (TCS) has partnered with a subsidiary of Financial Institutions, Inc. 'Five Star Bank' on its digital transformation journey.
EXAMIANS